Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and ...

Major stock indexes closed higher/lower on Friday, after the week saw a flurry of events including DeepSeek scare and ...

Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.

According to InvestingPro data, analysts maintain a strong bullish consensus on the stock, with price targets ... comparable weight loss to semaglutide before the 72-week mark noted in Novo ...

Courtesy Staci Rice, Classified as a GLP-1, appetite-suppressing medications, semaglutide is the active ... Staci Rice “I had a lot more confidence after that surgery,” Rice told The Post ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

President Trump held a phone call today with Vladimir Putin that he described as “lengthy and highly productive.” He ...

The drugmaker behind the medical phenomenon semaglutide, the key ingredient ... In December, shares in Novo Nordisk plunged after its newest weight loss drug, CagriSema, disappointed in weight ...

Beata Zawrzel / NurPhoto via Getty Images ... after reports that an activist investor has built a stake in the company and is pushing for change. Here's what investors need to know today. U.S ...

GREG BAKER / AFP via Getty Images U.S ... await earnings after the bell from Google parent Alphabet (GOOGL) and Advanced Micro Devices (AMD); Palantir (PLTR) stock is soaring in premarket trading ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...